Researchers unveil a groundbreaking hydrogel that mimics human skin's ability to heal itself rapidly, revolutionising ...

“Entanglement means that the thin polymer layers start to twist around each other like tiny wool yarns, but in a random order ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

Scientists have created a self-healing hydrogel that mimics human skin, offering a breakthrough solution for complete wound ...

Over a period of two weeks, the gel releases a small molecule, T-5224, that blocks the activation of adhesion-forming cells ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

This innovation could revolutionize applications like drug delivery, wound healing, soft robotics ... a UV lamp – similar to that used to set gel nail polish. ‘The UV-radiation from the ...

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

In a groundbreaking achievement, researchers from Aalto University and the University of Bayreuth have successfully developed a self-healing ...

The gel is designed to be a 'safe' debrider ... for factors that may influence debridement as well as healing of the wound. This will precede the confirmatory Phase III trials necessary for ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology ...